Prostate Cancer - Results from #27260

Optimization of PSA screening policies: A comparison of the patient and societal perspectives - Abstract October 14, 2011

Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: Can the change in prostate-specific antigen reliably guide prostate biopsy decisions? - Abstract October 14, 2011

Complete clinical and biological response to zoledronic acid in castrate-resistant prostate cancer metastatic to bone - Abstract October 14, 2011

Complications after radical prostatectomy: Anastomotic stricture and rectourethral fistula - Abstract October 14, 2011

MRI navigated stereotactic prostate biopsy : Fusion of MRI and real-time transrectal ultrasound images for perineal prostate biopsies - Abstract October 14, 2011

Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate specific antigen-era: Incidence and survival - Abstract October 13, 2011

Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer - Abstract October 13, 2011

Prostate cancer: Multiparametric MR imaging for detection, localization, and staging - Abstract October 13, 2011

Robotic prostate biopsy and its relevance to focal therapy of prostate cancer - Abstract October 13, 2011

Identifying how and for whom cognitive-behavioral stress management improves emotional well-being among recent prostate cancer survivors - Abstract October 13, 2011

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy - Abstract October 13, 2011

Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy - Abstract October 13, 2011

Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results - Abstract October 13, 2011

PCF responds to U.S. Preventive Services Task Force recommendation on PSA screening October 13, 2011

Editor's Commentary - Screening for prostate cancer with PSA testing: Current status and future directions, by Alan J. Wein, MD, PhD (Hon.) October 13, 2011

Primary prevention of urologic tumors: Prostate cancer - Abstract October 12, 2011

High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: Validation of a technique - Abstract October 12, 2011

Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images - Abstract October 12, 2011

Lymph node-positive prostate cancer: Current issues, emerging technology and impact on clinical outcome - Abstract October 12, 2011

Magnetic resonance spectroscopy: A promising tool for the diagnostics of human prostate cancer? - Abstract October 12, 2011

Page 1364 of 1451